ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,796Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 1802

$623K Total Retail Price of All Prescriptions

Rank: 41 out of 1802

332 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 436 310 1 2
FUROSEMIDE 434 389 2 5
OMEPRAZOLE 405 269 3 4
SIMVASTATIN 402 294 4 1
LISINOPRIL 356 260 5 3
AMLODIPINE BESYLATE 306 241 6 6
METOPROLOL TARTRATE 219 186 7 9
SERTRALINE HCL 216 118 8 20
WARFARIN SODIUM 198 155 9 7
HYDROCODONE-ACETAMINOPHEN 165 104 S3 10 10
DONEPEZIL HCL 162 162 11 26
POTASSIUM CHLORIDE 154 119 12 15
POLYETHYLENE GLYCOL 3350 154 107 12 29
METFORMIN HCL 148 70 14 11
LOSARTAN POTASSIUM 147 81 15 18
ATENOLOL 142 108 16 12
TRAMADOL HCL 139 129 17 22
NAMENDA 137 137 18 34
FLUOXETINE HCL 135 128 19 35
LANTUS 131 90 20 47
MIRTAZAPINE 114 101 21 38
METFORMIN HCL ER 105 43 22 46
RISPERIDONE 103 81 23 64
DIOVAN 98 98 24 57
GABAPENTIN 97 67 25 16
ALENDRONATE SODIUM 97 97 25 21
CARVEDILOL 96 79 27 36
SPIRIVA 88 69 28 72
TAMSULOSIN HCL 86 70 29 28
PANTOPRAZOLE SODIUM 85 69 30 44
ATORVASTATIN CALCIUM 82 60 31 14
CITALOPRAM HBR 80 53 32 17
MELOXICAM 79 51 33 59
HYDROCHLOROTHIAZIDE 78 45 34 8
LOVASTATIN 77 64 35 25
FENTANYL 75 75 S2 36 43
METOPROLOL SUCCINATE 72 51 37 13
ADVAIR DISKUS 70 42 38 32
KLOR-CON M20 66 65 39 86
ZOLPIDEM TARTRATE 65 48 40 27
NEXIUM 64 32 41 50
ABILIFY 63 29 42 143
AMITRIPTYLINE HCL 62 27 R 43 80
KLOR-CON M10 62 62 43 142
BUMETANIDE 60 40 45 102
ENABLEX 59 58 46 328
PREDNISONE 59 42 46 33
BUPROPION HCL SR 59 27 46 139
PROAIR HFA 56 0 49 58
CLOPIDOGREL 56 40 49 48
ALLOPURINOL 54 47 51 24
NOVOLOG 53 25 52 100
FENOFIBRATE 52 41 53 56
NYSTOP 50 47 54 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.